Safe Use of Ursodeoxycholic Acid in the Treatment of Dyspeptic Symptoms in Patients with Chronic Active Hepatitis: A Double-Blind Controlled Trial

Armitage P (1974) Statistical methods in medical research. Blackwell Scientific Publ., Oxford.

Baggenstoss A H Soloway R D Summerskill W H J Elveback L R Schoenfield L J (1972) Chronic active liver disease. The range of histologic lesions, their response to treatment and evolution. Human Pathology 4, 183.

Coltorti M Del Vecchio Blanco C Caporaso N Ambrogio G Krauss R Russo Mattera D (1978) Aspetti e problemi clinici delle epatiti croniche nel nostro paese. Rel Convegno su ‘Epatiti virali e meningoencefaliti’ Napoli 23–24 Novembre 1978. Atti Pacini Ed. Pisa, p 5.

Coltorti M Del Vecchio Blanco C Caporaso N De Carlo R (1980) Relationship between HBCAb and HBSAg or HBSAb in chronic hepatitis and healthy carriers in Campania (S. Italy). Italian Journal of Gastroenterology 12, 14.

Cook G C Mulligan R Sherlock S (1971) Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Quarterly Journal of Medicine 40, 159.

Fedorowski T Salen G Zaki G F Shefer S Mosbach EH (1978) Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid in the rhesus monkey. Biochemical and ultrastructural studies. Gastroenterology 74, 75.

Frigerio G (1979) Ursodeoxycholic acid (UDCA) in the treatment of dyspepsia: report of a multicentric controlled trial. Current Therapeutic Research 26, 214.

Gentile S Foglia F Grignl N Coltorti M (1980) Eliminazione plasmatica di rifamicina-SV in epatopatie croniche e nella sindrome di Gilbert. Riforma Medica 95, 7.

GIRC Inter-Hospital Clinical Research Group (1979) Effect of ursodeoxycholic acid (UDCA) on dyspepsia in patients with gallstones or other biliary tract anomalies. Current Therapeutic Research 26, 230.

GIRC Inter-Hospital Clinical Research Group (1981) Treatment of radiolucent gallstones with CDCA or UDCA. A multicenter trial. Digestion, 22.

Koretz R L Lewin K J Higgins J Fagen N D Gitnick G L (1980) Chronic active hepatitis. Who meets treatments criteria? Dig. Dis. Scie. 25, 695.

Leuschner V Leuschner M Hubner K (1981) Gallstone dissolution in patients with chronic active hepatitis. Abstr. from AGA, New York City, May 18–20.

Murray-Lyon I M Stern R B Williams R (1973) Controlled trial of prednisolone and azathioprine in active chronic hepatitis. Lancet 1, 735.

Plotz P H (1975) Asymptomatic chronic hepatitis. Gastroenterology 68, 1629.

Schalm S W Summerskill W H J Gitnick G L Elveback L R (1976) Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis B s Antigen. Gut 17, 781.

Soloway R D Summerskill W H J Baggenstoss A H Geall M G Gitnick G L Elvebach L R Schoenfield L J (1972) Clinical, biological and histological remission of severe chronic active liver disease. A controlled study of treatments and early prognosis. Gastroenterology 63, 820.